Publication dates

All regions

1-20 of about 1 500 reports for Phase Iii Clinical Trial

Purchase Reports From Reputable Market Research Publishers

Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] - Global Industry Analysis, Size, Share, Growth, Trends

Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] - Global Industry Analysis, Size, Share, Growth, Trends

  • $ 4 795
  • Industry report
  • February 2014
  • by Transparency Market Research

... Of pharmacovigilance market on the bases of clinical trials phases i.E. phase i to iii and post marketing surveillance (pms). We have also mapped the trend for preference of the pharmaceutical players for in ...

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Data

... Numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence ...

Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014

Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Data

... And their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also ...

Pharma Clinical Trial Services: World Market 2013-2023

Pharma Clinical Trial Services: World Market 2013-2023

  • $ 2 595
  • Industry report
  • January 2013
  • by Visiongain

... Emphasis on companies, competition and business outlooks.Leading companies and 2015 market valuewe predict that the overall world market for clinical trial services will reach $30.6Bn ...

CRO Quality Benchmarking - Phase II/III Service Providers (6th edition)

CRO Quality Benchmarking - Phase II/III Service Providers (6th edition)

  • $ 6 800
  • Industry report
  • March 2014
  • by Industry Standard Research

... Pra - premier research - quintiles - rho - sgs life sciences - tata - theorem - worldwide clinical trials cro quality benchmarking - phase ii/iii service providers (6th ...

NeuroSigma, Inc. - Product Pipeline Analysis, 2014 Update

NeuroSigma, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Sigma concentrates in preclinical research and development, as well as phase i, ii and iii clinical trials. The company's product pipeline includes etns and stns. Its trigeminal nerve stimulation is a medical ...

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 4 995
  • Industry report
  • June 2014
  • by GBI Research

... Compared with the standard treatment alone in clinical trials, it is expected to bear high market potential, given that its efficacy is translated into larger phase iii trials. The cancer vaccine ...

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

  • $ 3 500
  • Industry report
  • October 2013
  • by GBI Research

... The pipeline for mabs is analyzed on the basis of phase distribution, program type and molecular target, as is the entire pipeline for all molecule types.- Detailed analysis of pipeline drug clinical trials ...

2013 CRO Quality Benchmarking - Phase II/III Service Providers

2013 CRO Quality Benchmarking - Phase II/III Service Providers

  • $ 6 800
  • Industry report
  • April 2013
  • by Industry Standard Research

... This critical report offers insight into your service quality, your competitors' quality, buyers' needs, cro selection criteria, paths to differentiation, and clinical outsourcing trends and forecasts ...

Hepatitis C Market & Forecast, HCV Drugs Clinical Trials, Hepatitis C Pipeline Drugs Sales & Forecast - Worldwide

Hepatitis C Market & Forecast, HCV Drugs Clinical Trials, Hepatitis C Pipeline Drugs Sales & Forecast - Worldwide

  • $ 1 290
  • Industry report
  • July 2013
  • by Renub Research

... As a formidable challenge to prevention and care. Study titled Hepatitis c market & forecast, hcv drugs clinical trials, hepatitis c pipeline drugs sales & forecast - worldwide ...

About 3 200 reports for Phase Iii Clinical Trial

Download Unlimited Documents from Trusted Public Sources

Medinet Annual Report 2013

  • Http www edgar online com
  • January 2013
    171 pages
  • Equity Market  

    Preferred Stock  

    Common Stock  

  • United States  

View report >

35 Companies for Phase Iii Clinical Trial

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Johnson and Johnson

United States

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.